Visual hallucinations and psychotic symptoms during treatment with selective 
serotonin reuptake inhibitors: Is the sigma receptor involved? [Lett].

Schuld, A.; Archelos, J. J.; Friess, E.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: Is the sigma receptor involved? [Lett].

MPS-Authors

/persons/resource/persons80522

Schuld, A.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80327

Friess, E.
AG Friess, Elisabeth, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Schuld, A., Archelos, J. J., & Friess, E. (2000). Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: Is the sigma receptor involved? [Lett]. Journal of Clinical Psychopharmacology, 20, 579-580.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-A5CA-7

Abstract

There is no abstract available